| Liu, Ling |
NCT04845399: Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A |
|
|
| Completed | 3 | 101 | RoW | Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection | Zhengzhou Gensciences Inc, Jiangsu Gensciences lnc. | Hemophilia A | 06/21 | 06/21 | | |
SPH3127-301, NCT05359068: Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension |
|
|
| Completed | 3 | 957 | RoW | SPH3127 tablet, Valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Essential Hypertension | 12/23 | 12/23 | | |
NCT06038916: To Evaluate the Safety and Initial Efficacy of STSA-1002 Injection in Patients with Acute Respiratory Distress Syndrome |
|
|
| Recruiting | 1/2 | 60 | RoW | STSA-1002 Injection Placebo, STSA-1002 Injection | Staidson (Beijing) Biopharmaceuticals Co., Ltd | Acute Respiratory Distress Syndrome | 08/25 | 09/26 | | |
NCT06529445: Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects |
|
|
| Completed | 1 | 84 | RoW | High Dose VC004 Capsules, Median Dose VC004 Capsules, Low Dose VC004 Capsules | Jiangsu vcare pharmaceutical technology co., LTD | Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion | 08/24 | 08/24 | | |
NCT06619951: A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects |
|
|
| Completed | 1 | 56 | RoW | VC004 and Itraconazole, VC004 and rifampicin | Jiangsu vcare pharmaceutical technology co., LTD | Locally Advanced or Metastatic Solid Tumor | 10/24 | 10/24 | | |
NCT05219643: Effect of Nava on Weaning Outcome in Patients With Mechanical Ventilation |
|
|
| Recruiting | N/A | 130 | RoW | NAVA, PSV | Southeast University, China, First Affiliated Hospital of Wannan Medical College | ARDS | 12/24 | 02/25 | | |
| Shen, Yang |
NCT06173037: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer |
|
|
| Recruiting | 2 | 88 | RoW | RC88, RC88 for Injection | RemeGen Co., Ltd. | Primary Peritoneal Cancer, Fallopian Tube Cancer, Epithelial Ovarian Cancer | 06/26 | 12/26 | | |
NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer |
|
|
| Recruiting | 2 | 64 | RoW | GT101 injection, Gemcitabine injection | Grit Biotechnology | Adult | 01/27 | 01/27 | | |
NCT06251947: Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen |
|
|
| Recruiting | 2 | 83 | RoW | Efbemalenograstim Alfa | Shandong University, Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Ovarian Cancer, Cervical Cancer | 06/26 | 12/26 | | |
| ling, liu zi |
NCT05219643: Effect of Nava on Weaning Outcome in Patients With Mechanical Ventilation |
|
|
| Recruiting | N/A | 130 | RoW | NAVA, PSV | Southeast University, China, First Affiliated Hospital of Wannan Medical College | ARDS | 12/24 | 02/25 | | |
| Peng, Fei |
| No trials found |
